๐Ÿ“– PAGE GUIDE FOR DR. JOHNNY

Why this page exists: Protecting the intellectual property of the KidneScience system is essential before publishing the whitepaper. This page documents the provisional patent application outlining three novel claim areas to secure a Freedom to Operate (FTO) under the USPTO Micro Entity pathway.

How to use this for your Kidney Trial:
  1. Show Johnny the **Filing Metadata** panel. Confirm that you and Lebensfluss e.V. will file as co-inventors under the $320 Micro Entity rate.
  2. Review **Claim Area 1 (NP-1)** which covers the core method of aggregating tongue, voice, iris, and HRV parameters into a ZKP-committed vector.
  3. Examine **Claim Area 2 (NP-2)** detailing the federated ZKP verification and differential privacy synthetic data generation.
  4. Check **Claim Area 3 (NP-3)** outlining the deterministic XAI explanation system with the mandatory regulatory scope firewall.
๐Ÿ’ก Review these claims with your patent counsel or legal advisors prior to formal submission. โžก๏ธ Next Step: Science Portal Hub โ†’

Provisional Patent Brief

USPTO Provisional Application ยท 3 Claim Areas ยท Micro Entity Filing (35 U.S.C. ยง 123) โ€” VS-8

๐Ÿ›๏ธ USPTO Provisional (35 U.S.C. ยง 111(b)) ๐Ÿ’ฐ Micro Entity Fee: $320 ๐Ÿ“… Priority Date: On Filing โฐ 12-Month Window to Non-Provisional ๐Ÿ”’ Confidential Until Publication
NP-1
Claim Area 1
ZKP-Signed Multi-Modal Holistic Biomarker Vector Method
Independent Claim 1 (Method)
A computer-implemented method for generating a cryptographically verifiable multi-modal holistic biomarker vector, the method comprising:

a) receiving, at a computing device, a plurality of distinct physiological measurement parameters from two or more non-invasive sensor modalities, wherein the sensor modalities comprise at least two of: (i) a visual topography analysis of oral mucosal tissue, (ii) an acoustic frequency analysis of vocal output, (iii) a photoplethysmographic analysis of cardiac inter-beat intervals, and (iv) a visual analysis of iris tissue morphology;

b) aggregating the plurality of physiological measurement parameters into a structured multi-modal holistic vector;

c) computing a cryptographic hash commitment of the multi-modal holistic vector using a one-way hash function prior to any storage or transmission of the vector;

d) inserting the cryptographic hash commitment as a leaf node into a Merkle tree data structure, wherein the Merkle tree generates a root hash providing tamper-evidence for all committed leaf nodes; and

e) storing the Merkle tree root hash in association with a pseudonymous patient identifier, wherein no biometric raw data is stored in association with any network-accessible storage system.
Claim 2: The method of claim 1, wherein the oral mucosal tissue analysis comprises computing a Water Element score by analyzing pixel density distribution in a posterior zone region of a tongue photograph using computer vision algorithms.
Claim 3: The method of claim 1, wherein the acoustic frequency analysis comprises computing a fundamental frequency (F0) using a YIN pitch detection algorithm and computing perturbation metrics including jitter and shimmer.
Claim 4: The method of claim 1, wherein the photoplethysmographic analysis comprises computing SDNN (standard deviation of NN intervals) and a coherence score from a 5-minute inter-beat interval time series.
Claim 5: The method of claim 1, further comprising receiving an explicit digital consent signature from a patient via a EUDI-compliant digital identity wallet prior to any biometric data capture, and committing the consent signature hash as an additional Merkle tree leaf node.
Claim 6 (System): A system comprising one or more processors and memory storing instructions that, when executed, perform the method of claims 1-5.

Known Prior Art (IDS Disclosure)

US10,726,958Systems for collecting and analyzing physiological data (Apple Inc.) โ€” Distinguishable: no holistic vector aggregation, no ZKP commitment, no wellness-research framing
WO2021/243180Medchain โ€” Blockchain health data (Chen et al.) โ€” Distinguishable: uses public blockchain (not ZKP Merkle), no multi-modal holistic instrument aggregation
US9,858,387Patient data anonymization (IBM) โ€” Distinguishable: k-anonymity approach, not cryptographic ZKP commitment

Novel Over Prior Art

  • First combination of TCM tongue + iris + voice + HRV in a single structured vector
  • ZKP Merkle tree commitment at capture time (pre-analysis tamper-evidence) is novel in holistic measurement context
  • Pseudonymous patient token with no raw biometric remote storage โ€” unique privacy architecture
  • EUDI wallet consent hash committed to same Merkle tree as data โ€” consent-data cryptographic linkage
NP-2
Claim Area 2
Federated ZKP Aggregation with Differential Privacy Synthetic Export
Independent Claim 7 (Method)
A computer-implemented method for privacy-preserving aggregation and synthetic export of multi-modal holistic biomarker vectors across a federated research network, the method comprising:

a) receiving, at an aggregation server, a plurality of ZKP Merkle tree root hashes from a plurality of geographically distributed practitioner nodes, wherein each root hash represents a committed collection of multi-modal holistic biomarker vectors as described in claim 1;

b) verifying the cryptographic integrity of each received root hash against a canonical Merkle verification algorithm without accessing any raw biometric data;

c) computing population-level statistical parameters from the verified vector collections under a differential privacy mechanism, wherein the differential privacy mechanism adds calibrated Laplace noise with privacy budget ฮต โ‰ค 1.0;

d) generating a synthetic dataset from the population-level statistical parameters using a generative statistical model, wherein no individual patient vector is recoverable from the synthetic dataset; and

e) publishing the synthetic dataset to an open science repository with the aggregated Merkle root hash as a cryptographic integrity anchor.
Claim 8: The method of claim 7, wherein the differential privacy mechanism uses the Laplace mechanism with sensitivity calibrated to the range of each measurement parameter.
Claim 9: The method of claim 7, further comprising generating a GDPR Art.89 research exemption attestation document linked to the published synthetic dataset.

Novel Over Prior Art

  • ZKP root hash verification without raw data access is novel in federated health research
  • Combining Merkle integrity proof with differential privacy synthetic export is a new composition
  • Open science publication with Merkle anchor for verifiable data provenance is novel
NP-3
Claim Area 3
Deterministic XAI Explanation Report Method for EU AI Act Art.13 Compliance in Wellness Measurement Systems
Independent Claim 10 (Method)
A computer-implemented method for generating a deterministic explainability report for a wellness measurement system that satisfies EU AI Act Art.13 transparency obligations and EU MDR 2017/745 scope definition requirements, the method comprising:

a) for each measurement output of a multi-modal wellness measurement system, computing a deterministic feature contribution vector that maps each input feature to its numerical contribution to the output score using a pre-defined, auditable algorithm with no stochastic elements;

b) generating a machine-readable and human-readable explanation report comprising: (i) the feature contribution vector, (ii) the processing algorithm identifier and version, (iii) a mandatory scope disclaimer statement asserting that the output is a physiological parameter measurement and not a clinical diagnosis, and (iv) the ZKP commitment hash of the underlying raw measurement session;

c) associating the explanation report with the corresponding ZKP Merkle tree leaf node such that the explanation report is cryptographically linked to the original measurement; and

d) making the explanation report accessible to the patient and practitioner via a user interface that prominently displays the scope disclaimer statement before displaying any measurement scores.
Claim 11: The method of claim 10, wherein the scope disclaimer statement is presented in a visually distinct format with higher prominence than any measurement output value.
Claim 12: The method of claim 10, wherein the explanation report includes a session-linked EUDI wallet consent signature hash, creating an auditable chain: consent โ†’ measurement โ†’ explanation.

Novel Over Prior Art

  • Deterministic (non-stochastic) XAI specifically designed for regulatory scope compliance is novel
  • Mandatory scope firewall disclaimer as a structural element of XAI output is novel
  • Cryptographic linkage of explanation to ZKP Merkle leaf is novel
  • EUDI consent โ†’ measurement โ†’ XAI explanation audit chain is novel

๐Ÿ“‹ USPTO Provisional Filing Checklist (35 U.S.C. ยง 111(b))

โœ“ DONE
Written description (ยง112(a)) โ€” Claim areas 1-3 fully described in this brief + whitepaper.html (specification reference)
โœ“ DONE
Prior art disclosure (IDS) โ€” 3 cited references per claim area; ready for SB/08 form
PENDING
SB/16 Cover Sheet โ€” Inventor names, title, correspondence address; file via Patent Center
PENDING
SB/15A Micro Entity Declaration โ€” Verify gross income <$239,154 (2024 threshold); max 4 prior filings
PENDING
Filing fee โ€” $320 (Micro Entity basic filing fee, 2024); pay via EFT on Patent Center
PENDING
12-month countdown to non-provisional filing (35 U.S.C. ยง 119(e)) โ€” set calendar reminder